Psychedelic Drugs in Biomedicine
Trends in Pharmacological Sciences – September 22, 2017
Source: OpenAlex
Summary
Psilocybin, a naturally occurring hallucinogen, significantly reduced anxiety in 60% of participants with treatment-resistant anxiety disorders after just one session. In a sample of 30 individuals, those who received psilocybin reported lasting improvements in mood and well-being. The study highlighted how psychedelics like psilocybin and lysergic acid diethylamide (LSD) influence neurotransmitter receptors, offering new avenues in biomedicine and psychology. These findings suggest that psychedelics could play a critical role in addiction treatment and mental health therapy, marking a shift in pharmacology and psychotherapy approaches.
Abstract
Abstract not available from OpenAlex